XML 38 R23.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Supplemental Financial Information | 6 Months Ended
--- | ---
Jun. 30, 2018
Balance Sheet Related Disclosures [Abstract] |
Supplemental Financial Information | Note 17. Supplemental Financial Information Inventories consisted of the following (in thousands):
|  | June 30, 2018 |  | December 31, 2017
Raw materials |  | $ | 35,509 |  |  | $ | 39,810 |
Work-in-process |  | 22,573 |  |  | 18,206 |
Finished goods |  | 99,749 |  |  | 86,454 |
|  | $ | 157,831 |  |  | $ | 144,470 |
Inventories are reported net of the provision for obsolescence. The provision, which reflects normal obsolescence and includes components that are phased out or expired, totaled $9.3 million and $10.5 million at June 30, 2018 and December 31, 2017, respectively. Accrued liabilities and other consisted of the following (in thousands):
|  | June 30, 2018 |  | December 31, 2017
CRM purchase price adjustment payable to MicroPort Scientific Corporation |  | $ | 14,891 |  |  | $ | — |
Other amounts payable to MicroPort Scientific Corporation |  | 6,419 |  |  | — |
Product remediation (1) |  | 9,296 |  |  | 16,811 |
Legal and administrative costs |  | 12,619 |  |  | 6,082 |
Provisions for agents, returns and other |  | 6,236 |  |  | 8,134 |
Royalty costs |  | 3,162 |  |  | 3,615 |
Contract liabilities |  | 3,330 |  |  | 2,900 |
Restructuring related liabilities |  | 3,113 |  |  | 3,560 |
Derivative contract liabilities (2) |  | 2,719 |  |  | 1,294 |
Contingent consideration (3) |  | 2,684 |  |  | — |
Research and development costs |  | 1,172 |  |  | 797 |
Product warranty obligations |  | 940 |  |  | 1,476 |
Deferred consideration |  | — |  |  | 14,300 |
Uncertain tax positions |  | — |  |  | 2,536 |
Escrow indemnity liabilities - Caisson |  | — |  |  | 2,000 |
Government grants |  | — |  |  | 1,174 |
Other accrued expenses |  | 19,572 |  |  | 14,263 |
|  | $ | 86,153 |  |  | $ | 78,942 |
(1) | Refer to “Note 6. Product Remediation Liability”
(2) | Refer to “Note 10. Derivatives and Risk Management”
(3) | Refer to “Note 8. Fair Value Measurements”

X
- References No definition available. + Details
Name: | us-gaap_BalanceSheetRelatedDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -URI http://asc.fasb.org/topic&trid=2126967 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration